CG Oncology Ownership | Who Owns CG Oncology?
CG Oncology Ownership Summary
CG Oncology is owned by 13.63% institutional investors, 3.15% insiders, and 83.22% retail investors. Vanguard group is the largest institutional shareholder, holding 8.63% of CGON shares.
CGON Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | CG Oncology | 13.63% | 3.15% | 83.22% |
| Sector | Healthcare Stocks | 42.54% | 10.83% | 46.63% |
| Industry | Biotech Stocks | 45.22% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 6.58M | 8.63% | $264.93M |
| Decheng capital | 6.37M | 8.36% | $256.65M |
| Wellington management group llp | 5.51M | 7.23% | $222.05M |
| Blackrock funding, inc. /de | 4.59M | 6.02% | $184.74M |
| Fmr | 3.87M | 5.07% | $155.71M |
| Tcg crossover management | 3.67M | 4.81% | $147.84M |
| Braidwell lp | 3.28M | 4.31% | $132.25M |
| Foresite capital management vi | 2.22M | 2.91% | $89.48M |
| Alliancebernstein | 2.14M | 2.80% | $86.12M |
| Ubs group | 2.13M | 2.79% | $85.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Decheng capital | 6.37M | 44.78% | $256.65M |
| Foresite capital management v | 1.00M | 37.19% | $40.44M |
| Foresite capital management vi | 2.22M | 34.57% | $89.48M |
| Acorn capital advisors | 1.13M | 23.14% | $45.58M |
| Avidity partners management lp | 1.60M | 14.68% | $64.48M |
| Tcg crossover management | 3.67M | 7.27% | $147.84M |
| Kynam capital management, lp | 2.01M | 6.01% | $80.77M |
| Saturn v capital management | 579.89K | 5.12% | $23.36M |
| Rosalind advisors | 300.00K | 4.13% | $12.08M |
| Braidwell lp | 3.28M | 3.92% | $132.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 5.51M | 0.04% | 3.61M |
| Vanguard group | 6.58M | 0.00% | 670.77K |
| Clearbridge investments | 613.85K | 0.02% | 613.85K |
| Pictet asset management sa | 1.35M | 0.04% | 606.55K |
| Candriam s.c.a. | 1.04M | 0.22% | 274.31K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 642.41K | 0.00% | -1.23M |
| Deerfield management company, l.p. (series c) | - | - | -850.70K |
| Frazier life sciences management | - | - | -770.00K |
| Avoro capital advisors | - | - | -700.00K |
| Abg-wtt global life science capital partners gp | - | - | -495.53K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Clearbridge investments | 613.85K | 0.02% | 613.85K | $24.73M |
| Vestal point capital, lp | 175.00K | 0.32% | 175.00K | $7.05M |
| Pfm health sciences, lp | 157.87K | 0.49% | 157.87K | $6.36M |
| Nantahala capital management | 109.45K | 0.15% | 109.45K | $4.41M |
| First trust advisors lp | 75.54K | 0.00% | 75.54K | $3.04M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Advisornet financial | -2.00 |
| Parallel advisors | -3.00 |
| Quantbot technologies lp | -7.00 |
| Stephens consulting | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 59 | -64.88% | 10,389,844 | -86.31% | 13 | 0.14% | 25 | -78.63% | 20 | -28.57% |
| Jun 30, 2025 | 167 | 16.78% | 75,899,259 | 8.77% | 99 | 1.19% | 116 | 31.82% | 28 | -15.15% |
| Mar 31, 2025 | 144 | 1.41% | 70,762,639 | 10.06% | 92 | 1.01% | 88 | -7.37% | 34 | 25.93% |
| Dec 31, 2024 | 143 | 16.26% | 66,220,894 | 26.90% | 98 | 1.63% | 96 | 10.34% | 27 | 50.00% |
| Sep 30, 2024 | 123 | 10.81% | 52,183,069 | 20.58% | 77 | 1.84% | 87 | 14.47% | 18 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 17, 2025 | POST LEONARD E | - | Sell | $41.43K |
| Oct 13, 2025 | POST LEONARD E | - | Sell | $43.25K |
| Oct 09, 2025 | Mulay James | - | Sell | $259.67K |
| Sep 30, 2025 | POST LEONARD E | - | Sell | $200.45K |
| Sep 29, 2025 | Mulay James | - | Sell | $499.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 3 |
| 2025 Q3 | 1 | 15 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 4 |
CGON Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools